在大流行期间,我们对冠状病毒病-19相关的急性肾损伤学到了什么?

IF 1.4 4区 医学 Q2 Medicine
Noemí Del Toro-Cisneros, Adrián E Caballero-Islas, Juan C Ramírez-Sandoval, Juan M Mejía-Vilet, Mauricio Arvizu-Hernández, Gustavo Casas-Aparicio, Jonathan Chávez-Íñiguez, Lilia M Rizo-Topete, Olynka Vega-Vega
{"title":"在大流行期间,我们对冠状病毒病-19相关的急性肾损伤学到了什么?","authors":"Noemí Del Toro-Cisneros,&nbsp;Adrián E Caballero-Islas,&nbsp;Juan C Ramírez-Sandoval,&nbsp;Juan M Mejía-Vilet,&nbsp;Mauricio Arvizu-Hernández,&nbsp;Gustavo Casas-Aparicio,&nbsp;Jonathan Chávez-Íñiguez,&nbsp;Lilia M Rizo-Topete,&nbsp;Olynka Vega-Vega","doi":"10.24875/RIC.22000146","DOIUrl":null,"url":null,"abstract":"<p><p>Initial reports suggested that kidney involvement after coronavirus disease 19 (COVID-19) infection was uncommon, but this premise appears to be incorrect. Acute kidney injury can occur through various mechanisms and complicate the course of up to 25% of patients with COVID-19 hospitalized in our Institution, and of over 50% of those on invasive mechanical ventilation. Mechanisms of injury include direct kidney injury and predominantly tubular, although glomerular injury has been reported, and resulting from severe hypoxic respiratory failure, secondary infection, and exposure to nephrotoxic drugs. The mainstay of treatment remains the prevention of progressive kidney damage and, in some cases, the use of renal replacement therapy. Although the use of blood purification techniques has been proposed as a potential treatment, results to date have not been conclusive. In this manuscript, the mechanisms of kidney injury by COVID-19, risk factors, and the mainstays of treatment are reviewed.</p>","PeriodicalId":49612,"journal":{"name":"Revista De Investigacion Clinica-Clinical and Translational Investigation","volume":"74 6","pages":"302-313"},"PeriodicalIF":1.4000,"publicationDate":"2022-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What did we learn about coronavirus disease-19-associated acute kidney injury during the pandemic?\",\"authors\":\"Noemí Del Toro-Cisneros,&nbsp;Adrián E Caballero-Islas,&nbsp;Juan C Ramírez-Sandoval,&nbsp;Juan M Mejía-Vilet,&nbsp;Mauricio Arvizu-Hernández,&nbsp;Gustavo Casas-Aparicio,&nbsp;Jonathan Chávez-Íñiguez,&nbsp;Lilia M Rizo-Topete,&nbsp;Olynka Vega-Vega\",\"doi\":\"10.24875/RIC.22000146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Initial reports suggested that kidney involvement after coronavirus disease 19 (COVID-19) infection was uncommon, but this premise appears to be incorrect. Acute kidney injury can occur through various mechanisms and complicate the course of up to 25% of patients with COVID-19 hospitalized in our Institution, and of over 50% of those on invasive mechanical ventilation. Mechanisms of injury include direct kidney injury and predominantly tubular, although glomerular injury has been reported, and resulting from severe hypoxic respiratory failure, secondary infection, and exposure to nephrotoxic drugs. The mainstay of treatment remains the prevention of progressive kidney damage and, in some cases, the use of renal replacement therapy. Although the use of blood purification techniques has been proposed as a potential treatment, results to date have not been conclusive. In this manuscript, the mechanisms of kidney injury by COVID-19, risk factors, and the mainstays of treatment are reviewed.</p>\",\"PeriodicalId\":49612,\"journal\":{\"name\":\"Revista De Investigacion Clinica-Clinical and Translational Investigation\",\"volume\":\"74 6\",\"pages\":\"302-313\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2022-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista De Investigacion Clinica-Clinical and Translational Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.24875/RIC.22000146\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista De Investigacion Clinica-Clinical and Translational Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/RIC.22000146","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

最初的报告显示,冠状病毒病19 (COVID-19)感染后肾脏受累并不常见,但这一前提似乎是不正确的。急性肾损伤可通过多种机制发生,在我院住院的COVID-19患者中,高达25%的患者和超过50%的有创机械通气患者会使病程复杂化。损伤机制包括直接肾损伤,主要是肾小管损伤,尽管有肾小球损伤的报道,并且由严重缺氧呼吸衰竭、继发感染和暴露于肾毒性药物引起。主要的治疗仍然是预防进行性肾损害,在某些情况下,使用肾脏替代疗法。尽管已经提出使用血液净化技术作为一种潜在的治疗方法,但迄今为止的结果还不是结论性的。本文综述了COVID-19肾损伤的机制、危险因素和主要治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
What did we learn about coronavirus disease-19-associated acute kidney injury during the pandemic?

Initial reports suggested that kidney involvement after coronavirus disease 19 (COVID-19) infection was uncommon, but this premise appears to be incorrect. Acute kidney injury can occur through various mechanisms and complicate the course of up to 25% of patients with COVID-19 hospitalized in our Institution, and of over 50% of those on invasive mechanical ventilation. Mechanisms of injury include direct kidney injury and predominantly tubular, although glomerular injury has been reported, and resulting from severe hypoxic respiratory failure, secondary infection, and exposure to nephrotoxic drugs. The mainstay of treatment remains the prevention of progressive kidney damage and, in some cases, the use of renal replacement therapy. Although the use of blood purification techniques has been proposed as a potential treatment, results to date have not been conclusive. In this manuscript, the mechanisms of kidney injury by COVID-19, risk factors, and the mainstays of treatment are reviewed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
60
审稿时长
>12 weeks
期刊介绍: The Revista de Investigación Clínica – Clinical and Translational Investigation (RIC-C&TI), publishes original clinical and biomedical research of interest to physicians in internal medicine, surgery, and any of their specialties. The Revista de Investigación Clínica – Clinical and Translational Investigation is the official journal of the National Institutes of Health of Mexico, which comprises a group of Institutes and High Specialty Hospitals belonging to the Ministery of Health. The journal is published both on-line and in printed version, appears bimonthly and publishes peer-reviewed original research articles as well as brief and in-depth reviews. All articles published are open access and can be immediately and permanently free for everyone to read and download. The journal accepts clinical and molecular research articles, short reports and reviews. Types of manuscripts: – Brief Communications – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters to the Editor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信